Comments
Loading...

INmune Bio

INMBNASDAQ
Logo brought to you by Benzinga Data
$5.30
-0.16-2.98%
Last update: 3:30 PM
15 minutes delayed

INmune Bio (NASDAQ:INMB) Stock, Earnings Estimates, EPS, And Revenue

INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 30
EPS Estimate
$-0.560
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)
$85K

Analyze the earnings history of INmune Bio using advanced sorting and filters.

Data brought to you by Benzinga APIs

INmune Bio (INMB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-01$-0.50$-0.6320.6 %
Mar 20242024-05-09$-0.61$-0.53-15.1 %
Dec 20232024-03-28$-0.47$-0.44-6.82 %
Sep 20232023-11-01$-0.48$-0.41-17.1 %

INmune Bio (INMB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Mar 20242024-05-09$14.00K$30.00K-53.3 %
Dec 20232024-03-28$28.00K$40.00K-30.0 %
Sep 20212021-11-03$14.00K$970.00K-98.6 %

FAQ

Q

When is INmune Bio (NASDAQ:INMB) reporting earnings?

A

INmune Bio (INMB) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?

A

The Actual EPS was $-0.50, which beat the estimate of $-0.63.

Q

What were INmune Bio’s (NASDAQ:INMB) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch